KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBT Margin: 2017-2025

Historic EBT Margin for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -18.41%.

  • Moderna's EBT Margin fell 1953.00% to -18.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -141.26%, marking a year-over-year decrease of 9435.00%. This contributed to the annual value of -111.46% for FY2024, which is 5390.00% down from last year.
  • As of Q3 2025, Moderna's EBT Margin stood at -18.41%, which was up 96.80% from -576.06% recorded in Q2 2025.
  • Moderna's 5-year EBT Margin high stood at 75.02% for Q4 2021, and its period low was -892.59% during Q1 2025.
  • In the last 3 years, Moderna's EBT Margin had a median value of -122.57% in 2024 and averaged -332.91%.
  • Its EBT Margin has fluctuated over the past 5 years, first spiked by 161,505bps in 2021, then crashed by 68,122bps in 2024.
  • Over the past 5 years, Moderna's EBT Margin (Quarterly) stood at 75.02% in 2021, then tumbled by 4,247bps to 32.55% in 2022, then tumbled by 3,006bps to 2.49% in 2023, then crashed by 12,506bps to -122.57% in 2024, then tumbled by 1,953bps to -18.41% in 2025.
  • Its EBT Margin stands at -18.41% for Q3 2025, versus -576.06% for Q2 2025 and -892.59% for Q1 2025.